ArticleCancer research2025

Precision Epigenetic Reprogramming: CoREST Inhibition Sensitizes STK11-Mutant Tumors to Immune Checkpoint Blockade Therapy.

De-Chen Lin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.